3D-Cultured Mesenchymal Stem Cell-Derived Exosomes Embedded in a Hybrid Scaffold Enhance Diabetic Wound Healing by Promoting Angiogenesis.
Jiang L., Su H., Zhao H., Xu W., Zhang Y., Liu B.
Prospective Study on Diabetic Foot, Chronic Wound, published in FASEB J (2026) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Prospective Study
- Journal
- FASEB J (2026)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41511155
- DOI
- 10.1096/fj.202503039R
Abstract (original English)
Wound healing in patients with diabetes remains a notable clinical challenge, arising from mitochondrial dysfunction in endothelial cells, which in turn leads to insufficient neovascularization. An effective approach to treating diabetic wounds involves administering exosomes that promote angiogenesis. Exosomes derived from adipose-derived mesenchymal stem cells cultured in a three-dimensional environment (3D-Exo) surpass conventional exosomes in yield, quality, and functionality, offering promising potential for diabetic wound healing. The synergistic promotion of wound repair by a multifunctional 3D-Exo-loaded hybrid scaffold has rarely been reported, and the mechanism underlying their combinatorial effect remains unclear. Herein, direct-writing melt electrospinning (DME) was employed to fabricate a novel polycaprolactone (PCL) microfiber scaffold (DME scaffold, DMEs), integrated with gelatin methacryloyl (GelMA) and 3D-Exo. Characterization of DMEs + GelMA@3D-Exo was subsequently performed. In vitro, the hybrid scaffold demonstrated biocompatibility with human umbilical vein endothelial cells and showed potential to facilitate angiogenesis and collagen formation. In vivo, the application of DMEs + GelMA@3D-Exo improved collagen deposition, stimulated angiogenesis, and increased wound closure rates, surpassing those observed in the DMEs and DMEs + GelMA groups. The underlying
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level AMeta-analysisPubMed
Efficacy of Stem Cell-Derived Exosomes in Promoting Diabetic Foot Ulcer Healing: A Meta-Analysis of Preclinical Animal Studies.
Meta-analysis on Diabetic Foot, Chronic Wound, published in J Diabetes Res (2026) — summary generated from the PubMed abstract.
- 2026
J Diabetes Res - Level AMeta-analysisEurope PMC
Bone marrow-derived mesenchymal stem cells combined with intramuscular injection promote the healing of diabetic foot ulcers: a systematic review and meta-analysis
Meta-analysis with a reported sample of 2059 on Diabetic Foot, Chronic Wound, published in Front Endocrinol (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
- n = 2059
Front Endocrinol (Lausanne) - Level AMeta-analysisEurope PMC
Comparative efficacy of advanced therapeutic modalities for diabetic foot ulcers: a systematic review and meta-analysis including NPWT, stem cells, ESWT, and bioengineered treatments
Meta-analysis on Diabetic Foot, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.
- 2026
Front Bioeng Biotechnol - Level AMeta-analysisPubMed
Therapeutic potential of adipose-derived stem cells for diabetic foot ulcers: a systematic review and meta-analysis.
Meta-analysis on Diabetic Foot, Chronic Wound, published in Diabetol Metab Syndr (2025) — summary generated from the PubMed abstract.
- 2025
Diabetol Metab Syndr6 citations - Level AMeta-analysisPubMed
A meta-analysis on application and prospect of cell therapy in the treatment of diabetes mellitus.
Meta-analysis on Diabetic Foot, Autoimmune Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level AMeta-analysisEurope PMC
Comparison of the efficacy of 12 interventions in the treatment of diabetic foot ulcers: a network meta-analysis
Meta-analysis with a reported sample of 356 on Diabetic Foot, Chronic Wound, published in PeerJ (2025) — summary generated from the PubMed abstract.
- 2025
- n = 356
PeerJ1 citations